Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series

PURPOSE: Immune checkpoint blockade has led to a significant improvement of patient survival in metastatic colorectal cancer (CRC) with DNA mismatch repair-deficiency (dMMR)/microsatellite instability-high (MSI-H). However, not all these patients are sensitive to monoimmunotherapy. We firstly presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chengjing, Jiang, Ting, Xiao, Yajie, Wang, Qiaoxuan, Zeng, Zhifan, Cai, Peiqiang, Zhao, Yongtian, Zhao, Zhikun, Wu, Dongfang, Lin, Hanqing, Sun, Chao, Zhang, Rong, Xiao, Weiwei, Gao, Yuanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714781/
https://www.ncbi.nlm.nih.gov/pubmed/34975873
http://dx.doi.org/10.3389/fimmu.2021.784336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714781/
https://www.ncbi.nlm.nih.gov/pubmed/34975873
http://dx.doi.org/10.3389/fimmu.2021.784336

Ejemplares similares